Nitric Oxide Therapy Systems Market By Type (Portable Nitric Oxide Therapy Systems, Fixed Nitric Oxide Therapy Systems), By End Users (Hospitals, Homecare Settings, Clinics) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

Neonatal pulmonary hypertension occurs due to the abnormalities encountered in the normal circulatory transition which usually occurs after birth in the neonates. It is also considered as a syndrome due to the manifestation such as hypoxemia which is caused due to pulmonary hypertension and shunting of the blood at the ductus arteriosus and foramen ovale. Acute respiratory distress syndrome is an acute condition in which the diagnosis is done by measuring the ration of partial pressure of oxygen in the arteries to the fraction of oxygen in the inspired air is less than 200. Nitric oxide inhalation through the cyclic GMP induces vasodilation and promotes relief in neonate hypertension and acute respiratory distress syndrome.

The types segment includes the portable nitric oxide therapy systems and fixed nitric oxide therapy systems. The end users segment comprises of hospitals, homecare settings and clinics. Market estimation and data forecast for the duration 2016-2026 is taken into consideration for the types and end users segment.

In line with the scope of report the geographic segmentation is given as follows which includes 5 geographical regions including the major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Data forecast and market sizing for the duration 2016-2026 for the geography segment is taken in the scope of report.

Market assessment is an effective tool which give a brief understanding of the existing market trends and competitive landscape is useful in mapping the current business milieu existing in the nitric oxide therapy systems market. Company profiles section exhibits the diverse product range available for the treatment of pulmonary ailments such as neonate pulmonary hypertension and acute respiratory distress syndrome. The market leaders in global nitric oxide therapy systems market are Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals, Praxair, Inc. and Vapotherm.

Nitric Oxide Therapy Systems Market

Based on end users, the global nitric oxide therapy systems market is categorized into

  • Hospitals
  • Homecare Settings
  • Clinics

Nitric Oxide Therapy Systems Market

The inhalation of nitric oxide for 8 hours at 25 parts per million (ppm) results in nitric oxide toxicity. Manufacturers are constantly striving to design safety monitoring systems to deliver constant flow of nitric oxide in the ventilator circuit of patients.  Side stream analysis features are present in the nitric oxide delivery system to constantly monitor the concentration of Nitrogen dioxide, nitric oxide and oxygen. Recently NuMed Plus, Inc. has made a patent application for clinical inhaled nitric oxide delivery system primarily developed for providing high quality nitric oxide for medical office environment. Hospitals and clinics currently have a consolidated hold in the nitric oxide therapy systems market on account of rising prevalence of neonate pulmonary hypertension and increasing number of pediatric cardiopulmonary bypass surgery being performed. Homecare settings are rapidly using nitric oxide therapy systems for the treatment of acute respiratory distress syndrome in geriatric population. It is also used in combination with oxygen for the treatment of chronic obstructive pulmonary disease in adults.

For the purpose of this study, the global nitric oxide therapy systems market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Nitric Oxide Therapy Systems Market

As per the research findings of National Center for Health Statistics 2015 report, the age related mortality rate of acute respiratory distress syndrome is 5.01 per 100,000 persons in the United States. The mortality rate is higher in Caucasian males compared to the females. Rising prevalence of acute respiratory distress syndrome and presence of well-developed healthcare infrastructure makes North America the market leader in nitric oxide therapy systems. The mounting geriatric population seeking treatment for acute respiratory distress syndrome in homecare settings is huge in Western European region which influences the market growth of nitric oxide therapy systems in Europe. Rising prevalence of neonate pulmonary hypertension cases and competitive market created due to the emergence of local players supplying nitric oxide therapy systems contribute towards the positive market growth of Asia Pacific region.

Choose License Type
Published Date:  Jan 2018
Category:  Medical Devices
Report ID:   58965
Report Format:   PDF
Pages:   120
Rating:    4.2 (19)
Connect With Us
+1-408-641-3282
24/7 Research Support